factual

What is the specific name of the credit card liability related to BCBS for Best Brains?

Best_Brains Franchise · 2025 FDD

Answer from 2025 FDD Document

6 (
( Credit Card Liabilities
Credit Card at BOA4100 1,277.11 8,660.91
Credit Card at Chase 36,525.47 48,735.96
Chase United 29,956.61 434.79
Credit BCBS 3,726.42 1,405.36
Citibank AAdvantage 10,970.12 3,252.89
Total credit card Liabilities 82,455.73 62,489.91

Source: Item 21 — FINANCIAL STATEMENTS (FDD page 42)

What This Means (2025 FDD)

According to Best Brains' 2025 Franchise Disclosure Document, the specific name of the credit card liability related to BCBS (Blue Cross Blue Shield) is "Credit BCBS." As of December 31, 2023, the balance for this liability was $3,726.42, while on December 31, 2022, it was $1,405.36. This indicates an increase in the credit card liability associated with BCBS from 2022 to 2023.

For a prospective Best Brains franchisee, understanding these liabilities is crucial as it provides insight into the company's financial obligations. Credit card liabilities, in general, reflect short-term debts that Best Brains has incurred and needs to repay. The "Credit BCBS" line specifically suggests expenses related to health insurance or other services provided by Blue Cross Blue Shield.

Monitoring these liabilities can help a franchisee assess the financial health and management practices of Best Brains. An increasing balance, as seen with the Credit BCBS liability, might warrant further investigation to understand the underlying reasons and potential impact on the company's overall financial stability. It's important to note that these figures are part of a broader financial picture, and a comprehensive analysis would involve reviewing all liabilities and assets to gain a complete understanding.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.